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The dark side of the gut: Virome–host interactions in
intestinal homeostasis and disease
Yuhao Li1,2, Scott A. Handley2,3, and Megan T. Baldridge1,2
The diverse enteric viral communities that infect microbes and the animal host collectively constitute the gut virome.
Although recent advances in sequencing and analysis of metaviromes have revealed the complexity of the virome and
facilitated discovery of new viruses, our understanding of the enteric virome is still incomplete. Recent studies have
uncovered how virome–host interactions can contribute to beneficial or detrimental outcomes for the host. Understanding
the complex interactions between enteric viruses and the intestinal immune system is a prerequisite for elucidating their role in
intestinal diseases. In this review, we provide an overview of the enteric virome composition and summarize recent findings
about how enteric viruses are sensed by and, in turn, modulate host immune responses during homeostasis and disease.
Introduction
The human gastrointestinal tract harbors diverse populations
of bacteria, fungi, archaea, viruses, and eukaryotic micro-
organisms. This complex community of microbes, collectively
termed the enteric microbiota, provides tremendous enzymatic
capabilities and plays integral roles in host metabolism, im-
mune system development, colonization resistance against
pathogens, and local immune homeostasis (Belkaid and Hand,
2014; Buffie and Pamer, 2013; Gensollen et al., 2016; Rowland
et al., 2018). Thus, the human enteric microbiota is considered
to functionally serve as an essential “organ.” In addition to the
well-appreciated contributions of the enteric bacterial micro-
biota to both health and disease, recent studies have begun to
reveal that the enteric virome is also critical for homeostatic
regulation and disease progression, acting through both
virus–microbiome and virus–host interactions (Mirzaei and
Maurice, 2017; Mukhopadhya et al., 2019; Pfeiffer and Virgin,
2016; Virgin, 2014).
The intestinal virome is composed of a staggering diversity of
eukaryotic and prokaryotic viruses capable of infecting both
host cells and a wide range of microorganisms. Human intestinal
contents are estimated to contain at least 108–1010 virus-like
particles per gram, the composition of which is partially de-
fined by dietary habits and surrounding environment (Hoyles
et al., 2014; Lepage et al., 2008). Gut viral diversity is age de-
pendent across healthy, Western individuals, but in adults, viral
intrapersonal variance remains low (Garmaeva et al., 2019;
Gregory et al., 2020). Indeed, the adult human enteric virome is
highly individual and temporally stable and correlates with the
bacterial microbiome (Shkoporov et al., 2019). While gastroin-
testinal virus studies have historically focused on eukaryotic
viruses due to their well-known pathogenic impact, such as
acute gastroenteritis, on people of all ages around the world
(Oude Munnink and van der Hoek, 2016), prokaryotic viruses,
or bacteriophages, likely account for over 90% of the human
enteric virome (Guerin et al., 2018). Our understanding of how
enteric prokaryotic viruses directly or indirectly influence hu-
man health and disease is limited. However, owing to their sheer
diversity and their intimate interaction with bacterial microbial
ecology, enteric bacteriophages are likely to play numerous roles
in promoting a healthy enteric ecosystem aswell as participating
in enteric microbiota-associated disease.
Compared with the bacterial component of the intestinal
microbiota, study of the enteric virome is in its infancy, and
much work needs to be done to fully elucidate its impact on
human health and disease. Recent advances in high-throughput
sequencing technologies and bioinformatic analysis of “meta-
viromes” have facilitated the identification of unknown viruses
and added to our appreciation of the richness and complexity of
the human enteric virome (Garmaeva et al., 2019; Handley et al.,
2012; Norman et al., 2015; Santiago-Rodriguez and Hollister,
2019). Many virome studies have repeatedly shown that only a
minor fraction of sequences can be classified and that up to 90%
of virome sequences may go unannotated (Handley et al., 2016;
Manrique et al., 2016; Minot et al., 2011). The rest of the virome,
which cannot be assigned taxonomy, has been colloquially
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termed “viral dark matter” (Krishnamurthy and Wang, 2017).
Elucidation of the full composition of the human virome will be
paramount to our understanding of enteric viruses in health and
disease.
Because the enteric virome is a complicated menagerie of
both bacteriophages and eukaryotic viruses, as well as unre-
solved viral dark matter, it presents a substantial challenge to
researchers. Accurate interpretation of virome data requires an
understanding of bacteriophage and eukaryotic virology, bio-
informatics, microbial ecology, and enteric immunology/physi-
ology. While tools are improving to interrogate this complex
network, much additional work remains to crystalize our un-
derstanding of the virome in health and disease. Many other
reviews have surveyed the challenges presented by virome re-
search (Garmaeva et al., 2019; Khan Mirzaei et al., 2021; Wang,
2020). However, less attention has been spent on how a virome,
once characterized, can be integrated into classical models of
viral pathogenesis. Here, we will review the current under-
standing of sensing and immune regulation of the human en-
teric virome and how this may lead to important consequences
for health and disease.
Enteric virome composition
Bacteriophages
Metagenomic studies have shown that intestinal bacteriophages
are the most abundant components of the enteric virome (Focà
et al., 2015; Neil and Cadwell, 2018). Enteric phage populations
in adult humans appear to not be largely affected by periodic
fluctuations, remaining constant due to rapid adaptations to any
changes by long-termmembers of the virome (Minot et al., 2013;
Shkoporov et al., 2019). Early-life bacteriophage colonization
appears to originate from a combination of maternal, dietary,
and environmental sources and exists in a high predator–low
prey dynamic (Lim et al., 2015; Minot et al., 2011). Some infant
enteric microbiome studies have indicated early inverse corre-
lations between infant bacteriophage communities and bacterial
richness, with bacteriophage diversity rapidly decreasing in
early life, while others have suggested rapid early expansion of
phage communities from pioneer bacteria, followed by expan-
sion of eukaryotic virus populations (Liang et al., 2020; Lim
et al., 2015). Thus, the enteric virome, similar to the enteric
bacterial microbiome, exhibits dynamism during early life but
settles into a relatively stable configuration in adulthood.
Analysis of the enteric microbiome of healthy individuals has
revealed the presence of a healthy enteric phageome composed
of core bacteriophages common to healthy adults, which is likely
globally distributed (Manrique et al., 2016). The healthy enteric
phageome likely plays an important role in maintaining the
enteric microbiome structure and function (Lin and Lin, 2019).
Phages can be functionally grouped into two major categories
based upon their replicative life cycle (Lawrence et al., 2019).
Virulent phages are limited to a lytic lifestyle, whereby they
hijack the host cell’s replication mechanism of viral packaging,
ultimately lysing their bacterial host to release newly formed
progeny. In contrast, temperate phages have lytic but also ly-
sogenic life cycles, wherein they integrate their genetic material
into their host cell’s chromosome as prophages or remain as
circular or linear plasmids and passively replicate alongside the
host bacteria (Girons et al., 2000). The human enteric virome,
which exhibits a much lower ratio of phage:bacteria than other
environments, is dominated by temperate phages, which play
important roles in shaping the bacterial community and trans-
ferring genes among bacteria (Lin and Lin, 2019; Reyes et al.,
2012). These concepts support a dynamic environment wherein
bacteriophages participate in both taxonomic and functional
construction of a host enteric microbiome with potential
consequences of shaping either healthy or unhealthy enteric
environments.
Defined members of intestinal phage communities are pre-
dominantly members of the Caudovirales order or the Micro-
viridae family (Table 1; Callanan et al., 2018; Dion et al., 2020;
Gregory et al., 2019 Preprint). The tailed double-stranded (ds)
DNA viruses of Caudovirales include Siphoviridae (phages with
long, noncontractile tails, largely temperate), Myoviridae
(phages with long, contractile tails, strictly virulent), and Po-
doviridae (phages with short, contractile tails, largely virulent;
Santiago-Rodriguez and Hollister, 2019). The single-stranded
(ss) DNA members of the viral families Microviridae (phages
with small icosahedral capsid, temperate or virulent; Krupovic
and Forterre, 2011) and Inoviridae (phages with filamentous
morphology, temperate; King et al., 2011) have also been iden-
tified as important constituents of fecal viromes. Recently,
studies have identified DNA bacteriophages called crAssphages,
which are ubiquitous in publicly available metagenomes and
predominantly present in human feces (Dutilh et al., 2014).
Human gut–associated crAssphages are not a single entity but
rather a group of diverse crAss-like phages sharing genomic
traits, which can be classified into 10 candidate genera that
differ among human populations (Guerin et al., 2018). Based on
read co-occurrence analysis, the bacteria of phylum Bacter-
oidetes, which dominate the enteric microbiome, have been
pointed to as crAssphage hosts (Ahlgren et al., 2017; Dutilh et al.,
2014), and indeed, crAssphage ΦCrAss001 has been shown to
infect human gut symbiont Bacteroides intestinalis (Shkoporov
et al., 2018). However, our understanding of the biological sig-
nificance and role of crAssphage in the human intestine remains
limited. Despite the significant advances in human enteric
bacteriophage characterization made to date, only two RNA
bacteriophage families, Leviviridae (ssRNA) and Cystoviridae
(dsRNA), are currently known, and the role of RNA bacter-
iophages is poorly understood (Callanan et al., 2018). Whether
this is secondary to a more limited variety of RNA bacter-
iophages being present in the intestine or to undersampling due
to a frequent bias in virome library preparations toward ex-
clusively analyzing the DNA component (Garmaeva et al., 2019)
remains to be determined.
Eukaryotic viruses
Although bacteriophages are the most abundant viral commu-
nity in the human gastrointestinal tract, eukaryotic viruses are a
critically important virome component. Human virome studies
have revealed complex eukaryotic viral communities including
ssRNA, ssDNA, dsRNA, and dsDNA viruses, many of which have
a significant impact on human health (Table 1; Gregory et al.,
Li et al. Journal of Experimental Medicine 2 of 18
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Table 1. Human gut virome
Viral type Viral familial
taxonomy












Anelloviridae Primates Torque teno virus,
Torque teno midi virus,
Torque teno mini virus
Epithelial cells Hino and Miyata,
2007; Spandole et al.,
2015




Li et al., 2010
Geminiviridae Plants Tomato yellow leaf curl
virus
No evidence Zhang et al., 2006
Genomoviridae Humans, mammals,
birds, and fungi
Gemycircularvirus Unclear Gregory et al., 2020
Parvoviridae Vertebrates, insects Human bocavirus 2-4 Epithelial cells Emlet et al., 2020;
Guido et al., 2016
Double-
stranded




Favier et al., 2004




Emlet et al., 2020;







No evidence Gregory et al., 2020
Papillomaviridae Vertebrates Human papillomavirus
6, 18, 66
Epithelial cells Egawa et al., 2015;
Popgeorgiev et al.,
2013















Caliciviridae Vertebrates Human NoV, Sapovirus Epithelial (enteroendocrine)




Green et al., 2020;
Karandikar et al.,
2016
Astroviridae Vertebrates Human astrovirus Enterocytes, goblet cells Kolawole et al., 2019
Virgaviridae Plants Pepper mild mottle
virus, Tobacco mosaic
virus
No evidence Colson et al., 2010;
Zhang et al., 2006















Tapparel et al., 2013







Unclassified Fibroblasts Gregory et al., 2020
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Table 1. Human gut virome (Continued)
Viral type Viral familial
taxonomy














cells, type 1 pneumocytes,
intestinal epithelial cells
Corman et al., 2018
Alphaflexiviridae Plants, fungi Unclassified No evidence Gregory et al., 2020
Iflaviridae Insects Unclassified No evidence Gregory et al., 2020





Hepatitis E virus Hepatocytes, intestinal
epithelial cells
Oechslin et al., 2020
Double-
stranded
Picobirnaviridae Unclear: mammals or
bacteria

















NA Dion et al., 2020;
Székely and Breitbart,
2016





Myoviridae Bacteria, archaea phiBCD7, Bacillus phage
G, phiP-SSM4
NA Barylski et al., 2020;
Gregory et al., 2020;
Guerin et al., 2018;
Yutin et al., 2018








NA Barylski et al., 2020;
Gregory et al., 2020;
Guerin et al., 2018;
Yutin et al., 2018
Podoviridae Bacteria Enterobacteria phage
P22, phage T3
NA Barylski et al., 2020;
Gregory et al., 2020;
Guerin et al., 2018;
Yutin et al., 2018
crAss-like phages Bacteria P-crAssphage NA Barylski et al., 2020;
Gregory et al., 2020;
Guerin et al., 2018;





Leviviridae Bacteria Enterobacteria phage
MS-2
NA Callanan et al., 2018
Double-
stranded
Cystoviridae Bacteria Pseudomonas phage NA Callanan et al., 2018
NA, not applicable.
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2019 Preprint; Lozupone et al., 2012; Zhang et al., 2006). When
mediating pathogenic effects, they can infect human intestinal
cells and trigger immune responses, causing damage to the
epithelial lining and the absorptive villi, leading to acute
gastroenteritis, enteritis, colitis, or even oncogenesis (Emlet
et al., 2020; Lopetuso et al., 2016). Viral pathogens of the
families Parvoviridae (human bocavirus 2–4), Adenoviridae
(adenovirus serotypes 40 and 41), Caliciviridae (norovirus
[NoV] and sapovirus), Astroviridae (astrovirus), Picornaviri-
dae (entero-, kobu-, and parechoviruses), Coronaviridae (se-
vere acute respiratory syndrome [SARS] and SARS–CoV-2),
Hepeviridae (hepatitis E virus), and Reoviridae (rotavirus)
have all been implicated in acute gastrointestinal disease
(Table 1). Most enteric eukaryotic viruses are RNA viruses,
except for the parvoviruses and adenoviruses, and thus are
often undetected in viral metagenomics studies due to the
additional library preparation requirements needed to se-
quence viral cDNA. These viruses stimulate robust innate and
adaptive immune responses from the host, which contribute
to symptoms as well as to viral clearance and protection from
reinfection.
In addition to eukaryotic virome members causing sympto-
matic infections, other enteric viruses are present in the intes-
tine without clear roles as pathogens. Previous studies have
documented persistent shedding of enteric eukaryotic viruses
from Anelloviridae (Torque teno virus), Circoviridae (unclassi-
fied), Picobirnaviridae (picobirnavirus), and Picornaviridae
(human parechovirus 1) families in healthy infants or children in
longitudinal studies without causing symptomatic disease
(Kapusinszky et al., 2012; Zhao et al., 2017). The absence of
symptoms might reflect either a commensal viral infection with
no apparent harm to the host or that the immune system pre-
dominantly suppresses detectable effects of infection (Focà et al.,
2015; Okamoto, 2009; Virgin et al., 2009). In addition, patho-
genic viruses are often detected in the absence of symptoms. For
example, in the same cohorts, rotavirus and parvoviruses were
also observed in healthy children. NoV, currently the leading
cause of acute gastroenteritis outbreaks globally, can be shed
asymptomatically over long periods of time (Newman et al.,
2016). Even SARS–CoV-2, the viral pathogen responsible for
the 2019 worldwide pandemic, can infect intestinal epithelium
and is detectable in stool for at least 1–2 mo even with asymp-
tomatic infection (Lamers et al., 2020; Lee et al., 2020; Xie et al.,
2020; Zang et al., 2020). For many of these pathogens, it remains
unclear whether asymptomatic infections are secondary to
avirulent strains or host differences in susceptibility or re-
sponsiveness to infection. Other viruses from Herpesviridae
(EBV), Papillomaviridae (human papillomavirus 6, 18, 66), Pol-
yomaviridae (human polyomavirus), and Retroviridae (HIV)
families can continuously replicate or reactivate from latency
when host immunosurveillance fails, resulting in disease (Emlet
et al., 2020; Gootenberg et al., 2017; Virgin, 2014). Though
normally these asymptomatic viral infections don’t cause de-
tectable phenotypes in their hosts, they are persistently inter-
acting with the host immune system and may help maintain
tonic levels of protective immunity or conversely increase host
susceptibility to disease, depending upon context.
Interestingly, vertebrate, amoeba, insect, and plant viruses
have also been found in human intestinal samples, likely derived
from diet (Minot et al., 2011). An open discussion continues
about whether these diet-derived viruses could contribute to
gastrointestinal disease. For instance, pepper mild mottle virus,
the most abundant pathogenic plant virus in human fecal sam-
ples, has been associated with specific immune responses and
clinical symptoms in humans (Colson et al., 2010; Zhang et al.,
2006). Further investigation is needed to define the role of these
viruses in immune regulation and gastrointestinal disease.
Intestinal antiviral immune responses
The intestinal epithelium serves as a first line of defense, sep-
arating the underlying lamina propria from trillions of com-
mensal microorganisms in the intestinal lumen. The intestinal
epithelial cells (IECs) and mononuclear phagocytes as well as the
gut-associated lymphoid tissues (GALTs) together maintain the
intestinal barrier. These components play critical roles in spatial
segregation, microbial sensing, and immunoregulatory re-
sponses to prevent inflammation (Peterson and Artis, 2014).
Bacteriophages can affect the human host indirectly through
interactions with bacteria, but new evidence suggests they also
directly stimulate the immune system. Enteric eukaryotic vi-
ruses, due to their tropism for host cells, induce and modulate
host immune responses directly. The general virus sensors,
signaling pathways, and mononuclear phagocyte subsets of
enteric virome sensing have been extensively reviewed else-
where (Metzger et al., 2018), but here we provide a general
overview to highlight key pathways.
Overview of enteric antiviral immune responses
As frontline sensors for microbial encounters, pattern recogni-
tion receptors (PRRs) recognize commensal or pathogenic
microorganisms in the human gut and initiate innate immune
and antigen-specific adaptive immune responses. PRRs are
germline-encoded host sensors, including the membrane-
bound TLRs, C-type lectin receptors (CLRs), and cytoplasmic
cytosolic nucleotide-binding oligomerization domain–like re-
ceptors (NLRs), retinoic acid–inducible gene I (RIG-I)–like re-
ceptors, and DNA sensors (absent in melanoma 2 [AIM2]–like
receptors) and cyclic guanosine monophosphate–adenosine
monophosphate synthase (Kumar et al., 2011). Highly con-
served microbial-associated molecular patterns, pathogen-
associated molecular patterns (PAMPs), or damage-associated
molecular patterns are identified by these sensors to trigger an
array of canonical anti-microbial immune responses through the
induction of various inflammatory cytokines, chemokines, and
IFNs, which further induce IEC-secreted antimicrobial peptides
and mucus. These responses also mediate recruitment and acti-
vation of intestinal mononuclear phagocytes and promote the de-
velopment of pathogen-specific, long-lasting adaptive immunity
through B and T lymphocytes. PRR sensing in the intestinalmucosa
is strictly regulated to induce effective immune responses against
invasive pathogenic viruses and to maintain immune tolerance to
harmless commensals (Metzger et al., 2018). Thus, PRR sensing in
the enteric tissue is essential to maintaining intestinal homeostasis,
shaping the virome, and preventing intestinal pathology.
Li et al. Journal of Experimental Medicine 5 of 18
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Depending on the cellular localization and recognition pat-
tern of PRRs, viral sensing can be divided into two general
categories. First, cell-extrinsic recognition, which does not re-
quire the cell-expressing PRRs to be infected, is mediated by
transmembrane TLRs and CLRswhen viral components attach to
cell surfaces or are internalized into phagosomes or endosomes
(Bermejo-Jambrina et al., 2018; Iwasaki and Medzhitov, 2015;
Satoh and Akira, 2017). In general, recognition by TLRs and CLRs
does not depend on the viability, replication, or invasiveness of
foreign microbes and thus can detect a broad spectrum of mi-
crobial PAMPs regardless of their origin (Iwasaki and Medzhitov,
2015). In contrast, cell-intrinsic viral recognition relies on intra-
cellular cytosolic sensors to detect ligands that emerge in infected
cells. These include the RNA sensors of RIG-I–like receptors and
cytosolic DNA sensors, which are ubiquitously expressed in both
immune and nonimmune cells, as well as cytosolic NLRs (Iwasaki
and Medzhitov, 2010; Schroder and Tschopp, 2010). Intracellular
sensors are more restricted in their sensing spectrum, with PRR
recognition potentially depending on microbial viability, inva-
siveness, and replication.
Despite differential expression and patterns recognized by
individual PRRs, intestinal virus sensing triggers a cascade of
signals leading to the activation of NF-κB–dependent production
of proinflammatory cytokines including IL-1β, IL-6, IL-12, and
TNF-α and the activation of IFN regulatory factor (IRF) 3– and/
or IRF7-dependent transcription of type I and type III IFNs
(Kawai and Akira, 2011; Lazear et al., 2019). In addition, the
triggering of NLRs and AIM2 also leads to activation of the in-
flammasome, which induces caspase-1 to cleave immature forms
of cytokines such as pro–IL-1β and pro–IL-18, resulting in the
processing and secretion of mature cytokines IL-1β and IL-18
(Schroder and Tschopp, 2010). Type I IFNs, which include 13
members of the IFN-α family as well as IFN-β, IFN-ε, IFN-κ, and
IFN-ω, bind to the IFN-α/-β receptor (IFNAR) to activate the
Janus kinase-signal transduction and activation of transcription
(JAK–STAT) signaling pathway. Signaling through IFNAR sub-
sequently induces over 300 IFN-stimulated genes (ISGs), which
play critical roles in viral control by interfering with multiple
stages of viral life cycles. IFNAR signaling further induces the
transcription of IRF7, leading to positive feedback of the IFN
response (Honda et al., 2005). Type I IFNs also confer antiviral
resistance to neighboring uninfected cells, activate the cytotoxic
activity of natural killer cells and CTLs for clearance of virus-
infected cells, and induce cytokines and chemokines for the
initiation of adaptive immunity (Pang and Iwasaki, 2012). Type
III IFNs can consist of up to four IFN-λmolecules, IFN-λ1 (IL-29),
IFN-λ2 (IL-28A), IFN-λ3 (IL-28B), and IFN-λ4. Similar to type I
IFNs, IFN-λ cytokines signal through the IFN-λ receptor, which
is composed of two subunits, IL28Rα and IL10Rβ, leading to
activation of JAK–STAT signaling, expression of ISGs, and in-
duction of an antiviral state. However, unlike type I IFNs, which
mediate effects on virtually all cell types, IFN-λ primarily reg-
ulates antiviral immunity at barrier sites including the intestine
(Sommereyns et al., 2008). Expression of the IL28Rα subunit is
limited to specific cellular subsets, including epithelial cells of
the gastrointestinal tract, respiratory tract, and reproductive
tract and a specific subset of immune cells (Stanifer et al., 2019).
Interactions between enteric bacteriophages and the host
immune system
Indirect influences of phages on immune responses. Intestinal
bacteriophage communities are specifically related to and in-
terdependent upon their bacterial host communities, and in-
teractions between phages and bacterial hosts also influence the
eukaryotic host intestinal immune system. The balance between
lytic and lysogenic bacteriophage life cycles and differential
spatial distribution of phages contributes to the eubiosis of the
human microbiome, which is heavily implicated in the devel-
opment of immune cells and the regulation of immune responses
(De Paepe et al., 2014; Manrique et al., 2017). Bacteriophages
accumulate on enteric mucosal surfaces and within mucus, near
the frontline of defense against pathogens, at a high bacterio-
phage-to-bacteria ratio relative to the adjacent environment
(Barr et al., 2013). Binding interactions between mucin and Ig-
like protein domains exposed on phage capsids facilitate en-
richment of phages at mucus glycoproteins, thereby providing
ubiquitous non–host-derived immunity against bacterial in-
vaders (Almeida et al., 2019; Barr et al., 2013).
While this enrichment may provide a protective function,
phage-mediated bacterial cell lysis can release PAMPs, such as
bacterial DNA, LPS, peptidoglycan, and bacterial amyloid, which
can induce proinflammatory responses in the gut (Fig. 1; Sinha
and Maurice, 2019; Tetz and Tetz, 2018). In addition, a recent
gnotobiotic mouse study reported that bacteriophage predation
does not merely affect susceptible bacteria but also induces
cascading disturbances to other bacterial species via inter-
bacterial interactions (Hsu et al., 2019). Microbiome shifts
caused by bacteriophage predation can have a direct impact on
enteric metabolites, such as short-chain fatty acids, neuro-
transmitters, amino acids, and bile salts, which play key roles in
neuro-immunoendocrine regulation (Hsu et al., 2019; Sokol
et al., 2009).
In addition to directly affecting microbiome dynamics via
lysis of bacterial hosts, bacteriophages dramatically influence
host bacterial communities through horizontal transfer of novel
genes, which can provide resistance to subsequent phage pre-
dation and alter host gene expression, as well as influence the
physiology of the host (Fig. 1; Howard-Varona et al., 2017;
Lekunberri et al., 2017; Touchon et al., 2017). As discussed above,
prophages can integrate into bacterial chromosomes or be
maintained as plasmids within host cells, and these acquired
genes may contribute to bacterial adaptation (Modi et al.,
2013). Bacteriophage-mediated genetic transfer can even oc-
cur between distinct species of bacteria; for example, phages
from pathogenic bacteria can convert nonpathogenic bacteria
to virulent strains by transferring phage-encoded virulence
factors or other proteins that assist in immune evasion
(Broudy and Fischetti, 2003; Chen and Novick, 2009; Faruque
et al., 1999; Fillol-Salom et al., 2019). Carriage of Shiga
toxin–encoding prophages not only disseminates toxin genes
but also enhances antimicrobial tolerance of Escherichia coli by
modifying the bacterium’s metabolism (Holt et al., 2017).
Thus, phage-mediated horizontal transfer of genes can indi-
rectly modulate immune responses to the intestinal microbial
community.
Li et al. Journal of Experimental Medicine 6 of 18
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Figure 1. Indirect and direct influences of bacteriophages on immune responses. (1) Phage-mediated bacterial cell lysis can release PAMPs, which can
transit through the intestinal epithelium and induce proinflammatory responses. Bacteriophage tail adhesins can bind LPS to dampen LPS-induced immune
responses. (2) In the case of imbalanced phage communities, bacteriophage infection may dramatically influence the host bacterial community and lead to
Li et al. Journal of Experimental Medicine 7 of 18
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Other indirect effects of bacteriophages on the intestinal
environment have also been described, as phage tail fibers and
exposed protein coats can serve as binding sites for other
physiologically relevant products beyond mucus (Sinha and
Maurice, 2019). The needle domain of the bacteriophage tail fi-
ber region can bind and sequester iron ions, which can play
important roles in virulence, tolerance, and replication of in-
testinal bacterial pathogens including Vibrio vulnificus, Samonella
typhimurium, and Yersinia species (Kortman et al., 2014; Nazik
et al., 2017; Penner et al., 2016). In addition, recent studies have
also found that bacteriophage tail adhesins can bind LPS to
dampen LPS-induced immune responses (Miernikiewicz et al.,
2016). Thus, intestinal bacteriophage can serve as iron chelators
or LPS adsorbers to modulate bacterial communities as well as
inflammatory responses in this complex microbial ecosystem
(Fig. 1). As we continue to uncover and characterize additional
phages, it is likely that other mechanisms of modulationwill also
be discovered.
Direct influences of phages on immune responses. Until re-
cently, intestinal bacteriophages were thought to only affect
human immunity indirectly via effects on the microbiota.
However, growing evidence suggests that phages can cross the
intestinal epithelium to directly communicate with the enteric
immune system. In addition to passing through the epithelial
barrier when it is damaged due to inflammatory processes,
phages can also be internalized by nonspecific transcytosis and/
or by binding to moieties that resemble bacterial phage re-
ceptors (Sinha and Maurice, 2019). A Trojan horse hypothesis
has also been presented, suggesting that infecting bacteria may
act as delivery vehicles for phages to enter epithelial cells, al-
though there is currently no evidence to support this hypothesis
(Duerkop and Hooper, 2013; Sinha and Maurice, 2019). Tra-
versing or internalized bacteriophages can directly interact with
the epithelium, penetrate local dendritic cells (DCs), or drain
into the GALT to stimulate innate immune responses in antigen-
presenting cells to generate humoral immune responses (Fig. 1).
Previous studies have suggested that phages have either
weak proinflammatory or immunomodulatory effects, making
them potentially promising for medical application in phage
therapies (Miernikiewicz et al., 2013; Principi et al., 2019). The
production of ROS by immune cells, induced by LPS or E. coli, as
well as NF-κB activity can be inhibited by T4 and Staphylococcus
aureus phage (Górski et al., 2006; Miedzybrodzki et al., 2008;
Zhang et al., 2018). Further, purified phage proteins have been
shown to modulate anti-inflammatory responses similar to
functional phage (Miernikiewicz et al., 2016). However, because
there is such a vast diversity of phages, it is likely that a distinct
phage can elicit either anti-inflammatory or proinflammatory
immune responses (Górski et al., 2017; Van Belleghem et al.,
2017). Studies in this area have been generally limited to
cultivatable phage, and further studies on the immunobiological
activities of bacteriophages and their proteins are greatly
needed.
Gut-resident mononuclear phagocytes play central roles in
the migration and activation of immune cells by sensing mi-
crobes to trigger cytokine and chemokine responses, as well as
internalizing and digesting antigens for priming of intestinal T
and B cell responses. A significant expansion of Caudovirales
phages has been associated with inflammatory bowel disease
(IBD), and increased phages that target the beneficial microbe
Faecalibacterium prausnitzii have also been observed in IBD
(Cornuault et al., 2018; Norman et al., 2015). Recently, bacter-
iophages isolated from IBD patients were found to elicit
heightened T cell immune responses, dependent on interac-
tions with DCs (Gogokhia et al., 2019). These phages are en-
docytosed by intestinal DCs and, via TLR9 within endosomes,
stimulate both phage-specific as well as nonspecific IFN-
γ–mediated immune responses, which can exacerbate colitis,
supporting direct proinflammatory roles for phages in the
context of IBD (Gogokhia et al., 2019). During bacterial in-
fections, bacteriophages may also play proinflammatory roles.
Phage produced by pathogenic bacteria can be internalized by
human andmurine immune cells, with phage RNA subsequently
triggering TLR3- and Toll/IL-1 receptor–domain-containing
adapter-inducing IFN-β (TRIF)–dependent type I IFN produc-
tion while inhibiting phagocytosis and TNF production (Sweere
et al., 2019). These antiviral responses suppress bacterial clear-
ance, resulting in phage-facilitated bacterial infection (Sweere
et al., 2019). Thus, direct interactions of phage with mamma-
lian cells can have profound and direct effects on intestinal in-
fection and inflammation.
Previous studies have demonstrated that bacteriophages are
able to elicit specific humoral immune responses, which could
limit further systemic phage dissemination (Fig. 1; Hodyra-
Stefaniak et al., 2015; Pyun et al., 1989; Uhr and Finkelstein,
1963; Uhr et al., 1962). However, the factors that determine
bacteriophage immunogenicity, as well as how specific hu-
moral responses affect phages, are unclear. While antibodies
that bind to the tail fiber region to inhibit the interaction of
phage with bacterial hosts have long been understood to
neutralize phage infectivity, antibody responses against the
phage capsid protein are also capable of suppressing phage
activity (Dąbrowska et al., 2014; Yanagida, 1977). Long-term
exposure to high bacteriophage titers in drinking water in-
duces both secretory anti-phage IgA antibodies in the gas-
trointestinal tract, which limit phage activity in the gut, as
well as specific IgG, IgM, and IgA antibodies in blood
(Majewska et al., 2015; Majewska et al., 2019). Additional
exploration will be needed to fully define the effects of phage
in modulating innate and adaptive immune responses, as well
overgrowth of pathogens. The needle domain of the bacteriophage tail fiber region can bind and sequester iron ions and prevent pathogen overgrowth in the
intestine. (3) Transfer of prophage-encoded genes can influence the pathogenicity of bacterial hosts and provide immune evasion capacity by directly inhibiting
phagocytic cells. (4–6) Phages may also directly pass through damaged epithelial cells (4) or cross through the intestinal epithelium by nonspecific transcytosis
(5) or via specific recognition of eukaryotic cells via structures that resemble bacterial receptors (6). These invading phages can interact with the intestinal
immune system to induce pro- or anti-inflammatory responses and production of phage-specific neutralizing antibodies. Image created with BioRender.
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as in clarifying how the adaptive immune system may shape
phage communities in the microbiota.
Eukaryotic viruses and the immune system
In the mammalian intestine, eukaryotic viruses interact directly
with host cells to stimulate innate and adaptive responses. Much
of our understanding of these intestinal immune responses re-
lies upon murine models for human viral infections to effec-
tively dissect pathways by which the host responds to viral
challenge. Here, we describe recent findings related to host
immune responses to murine enteric viral infections, which are
likely to broadly reflect human enteric viral infections.
Cell intrinsic and innate responses to enteric eukaryotic
viruses. Invading viral nucleic acids are sensed by cell intrinsic
PRRs, which include endosomal TLRs that signal through
adaptor protein Myeloid differentiation primary response 88
(MyD88; for TLR7/8/9) or TRIF (for TLR3/4), as well as the cy-
tosolic sensors RIG-I and melanoma differentiation–associated
protein 5 (MDA5) that signal through mitochondrial antiviral-
signaling protein (MAVS). These PRR pathways ultimately
stimulate the activation of IRF3/7 and subsequent production of
types I and III IFNs and other antiviral or immunoregulatory
genes (Fig. 2; Hartmann, 2017; Onoguchi et al., 2007). For ex-
ample, the RIG-I/MDA5–MAVS pathway has been demonstrated
to be essential for induction of IFNs in rotavirus-infected IECs
and has a functionally important role in determining the mag-
nitude of rotavirus replication in the intestinal epithelium
(Broquet et al., 2011; Ding et al., 2018; Sen et al., 2011). Murine
NoV (MNoV) infects both IECs and immune cells including
macrophages, DCs, B cells, and T cells in GALT (Grau et al., 2017;
Wilen et al., 2018), and sensing of these ssRNA viruses has been
shown to rely on TLR3, TLR7, and MDA5, followed by phos-
phorylation of IRF3 and IRF7 through two independent path-
ways in infected cells (MacDuff et al., 2018; McCartney et al.,
2008; Thackray et al., 2012). Cytosolic NLRs also contribute to
control of enteric virus infections (Kanneganti, 2010). NLRP6
senses viral RNA via the RNA helicase Dhx15 and interacts with
MAVS to induce both type I and type III IFNs, and Nlrp6-
deficient mice exhibit increased intestinal viral loads of multi-
ple enteric viruses (Wang et al., 2015). NLRP9b, which is
specifically expressed in IECs, restricts the replication of rota-
virus in IECs, indirectly binding short rotavirus-derived dsRNAs
via the RNA helicase DHX9, leading to inflammasome formation,
release of active IL-18, and pyroptosis of the infected cell (Zhu
et al., 2017). It has been suggested that NLRP6 and NLRP9b,
expressed in different regions of the intestine, may cooperate in
defense against enteric viruses with distinct tropisms (Li and
Zhu, 2020). Sensing of intestinal eukaryotic viruses is thus
tightly controlled by a variety of PRRs.
Ultimately, host sensing of eukaryotic virus sensing culmi-
nates in production of different types of IFN, which serve to
control several aspects of enteric viral infection (Ingle et al.,
2018). Although MNoV infections in immunocompetent mice
are typically asymptomatic, mice lacking type I IFN signaling
succumb to lethal infection by acute MNoV strains (e.g., CW3,
MNV-1; Karst et al., 2003; McCartney et al., 2008; Nice et al.,
2016; Thackray et al., 2012). However, for persistent MNoV
infection (e.g., CR6), type I IFNs do not control viral loads in the
intestine but prevent spread of virus from the intestine to sys-
temic sites. Instead, IFN-λ has a profound antiviral effect on
persistent and acute MNoV infection (Baldridge et al., 2017;
Baldridge et al., 2015; Grau et al., 2020; Nice et al., 2015). Spatial
as well as kinetic differences in type I and type III IFN responses
highlight IFN-λ as important for front-line protection at the
intestinal epithelial barrier, while type I IFNs affect broad sys-
temic control of infections and consequent immune pathology
(Ingle et al., 2018). For other enteric viruses such as rotavirus,
type I and III IFNs both mediate development-specific roles in
viral control (Lin et al., 2016; Pott et al., 2011).
Indeed, IFN responses are so central to regulation of enteric
virus infection that many viruses have developed strategies to
evade PRR detection, IFN production, and downstream activa-
tion of antiviral proteins (Beachboard and Horner, 2016; Ingle
et al., 2018). For instance, secretion of nonstructural protein NS1
from a persistent MNV strain facilitates evasion of IFN-
λ–mediated antiviral immunity and IEC tropism (Lee et al.,
2019; Lee et al., 2017). The nonstructural protein 1 (NSP1) and
structural protein VP3 of rotavirus also directly antagonize host
innate immune responses. Putative E3 ubiquitin ligase NSP1
mediates degradation of a wide range of cellular factors includ-
ing RIG-I and IRFs, while VP3 utilizes a 2H-phosphodiesterase
domain to prevent activation of antiviral factors (Morelli et al.,
2015).
Importantly, the innate response to intestinal viral infections
does not only affect the inducing virus but may also confer in-
terference against secondary enteric virus infections (Ingle
et al., 2019; Wang et al., 2012). Although mechanisms of viral
interference in the intestine have not yet been well studied, the
presence of murine astrovirus in immunodeficient mice confers
protection against other enteric viral challenges via the induc-
tion of IFN-λ (Fig. 2; Ingle et al., 2019). Conversely, it is possible
that viral adaptations to evade immune responses may in some
circumstances limit innate responses to multiple coinfecting
viruses, though this remains to be explored.
Adaptive responses to enteric eukaryotic viruses. Adaptive
cellular and humoral immune responses are essential for the
control of commensal microbes and eradication of invading vi-
ruses (Da Silva et al., 2017; Spencer and Sollid, 2016). As the
major antigen-presenting cells of the intestinal immune system,
conventional DCs that have acquired antigens migrate to the
intestinal-draining mesenteric lymph nodes in a CCR7-
dependent manner, where they present processed antigen to
cells of the adaptive immune system (Jang et al., 2006). Previous
studies have found that both B cell and T cell responses are re-
quired for efficient clearance of NoV and rotavirus infection
from the intestine and mesenteric lymph nodes (Fig. 2; Chachu
et al., 2008a; Chachu et al., 2008b; Offit, 1994; Ray et al., 2007).
MNoV-specific CD8+ T cells of the intestinal mucosa are a crucial
component of NoV immunity for acute strains, though persis-
tent strains induce fewer and less functional T cells and avoid
adaptive immune responses in their immune-privileged niche
(Tomov et al., 2013; Tomov et al., 2017). Functional human NoV-
specific memory T cell responses have been demonstrated in
healthy adults and children, and recent ex vivo expansion of
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these T cells has highlighted the potential of adoptively trans-
ferred T cell therapy for the treatment of chronic NoV infection
(Hanajiri et al., 2020; Malm et al., 2019; Malm et al., 2016).
Murine rotavirus–specific CD8+ T cells play an important role in
the timely resolution of primary infection, and they can also
provide short-term partial protection against reinfection
(Franco et al., 2006). Cellular adaptive immune responses are
thus important for pathogen clearance.
Intestinal humoral immune responses are driven chronically
by enteric antigens, ultimately generating the largest population
of antibody-producing plasma cells (PCs) in the body, which play
crucial roles in shaping the persistent enteric humoral response
and maintaining intestinal homeostasis (Fig. 2). The PCs of the
gastrointestinal mucosa secrete IgA, IgM, and IgG to control and
prevent infection; these antibodies may act in a variety of ways
to neutralize viral infections. Secretory IgA is a key component
in host–microbiota interactions, as defects in secretory IgA lead
to overstimulation of innate immunity by IECs and dysbiosis of
the intestinal microbiota (Kawamoto et al., 2012; Shulzhenko
et al., 2011). Human NoV–specific IgA has been shown to con-
fer protection from gastroenteritis and is also inversely corre-
lated with both virus levels in stool and duration of virus
shedding, indicating that IgA is likely important for viral
clearance (Ramani et al., 2015). IgA-mediated protection against
human NoV may rely specifically on blocking viral attachment
to cellular receptors (Sapparapu et al., 2016). Previous studies
have shown that rotavirus-specific B cell activation depends on
plasmacytoid DCs and that rotavirus-primed memory B cells
Figure 2. Eukaryotic virus interactions with the intestinal immune system. In homeostatic states, commensal viruses stimulate basal type I IFN and IL-15
expression that maintains the antiviral state and sustains intestinal homeostasis. Type I IFNs stimulate IL-22 production from innate lymphoid cells to protect
IECs, and IL-15 promotes IEL biogenesis. In the case of enteric viral infections, IFN-λ is induced, likely from epithelial cells, to protect IECs from epithelial tropic
viruses including rotavirus, NoV, and astrovirus. Viral pathogens can also transit through the epithelium to infect or induce immune responses from lym-
phocytes or phagocytes in the lamina propria. The induction of type I IFNs mediates broad systemic control of infections but can also contribute to consequent
immune pathology. During viral infection, intestinal phagocytes including lamina propria DCs, macrophages, and DCs in the epithelial dome of Peyer’s patches
can also sample viral antigens at various sites. Antigen-laden DCs migrate to the mesenteric lymph nodes, where they present processed antigen and induce T
and B cell responses. Induced B cells can differentiate into PCs, which home to the lamina propria and secrete antigen-specific IgG, IgM, and IgA. These Igs
transcytose across the epithelial cell layer to provide protection against intestinal viral infection. Solid lines indicate the migration of immune cells, while
dashed lines indicate secretion of antibodies and cytokines to the intestinal lumen. Image created with BioRender.
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provide long-term protection against rotavirus infection (Deal
et al., 2013; Franco et al., 2006). Anti-rotavirus non-neutralizing
IgA antibodies, which can be developed by infants and young
children with natural infections or following rotavirus vacci-
nation, are protective in vivo (Afchangi et al., 2019; Burns et al.,
1996) and, interestingly, can transmit into IECs via transcytosis
to block rotavirus maturation inside cells (Aiyegbo et al., 2013).
While Igs clearly play an important role in the host antiviral
response, further investigation will be critical to fully under-
stand the complex interactions between humoral immune re-
sponses and eukaryotic viral pathogens.
Adaptive immune responses have also been shown to be
critical for maintenance of a homeostatic virome. In the context
of dysfunctional T cell responses secondary to simian immu-
nodeficiency virus (SIV) or HIV/AIDS, substantial virome al-
terations have been observed. Pathogenic SIV infection in
rhesus monkeys is associated with a dramatically expanded
enteric virome, including adenoviruses, caliciviruses, parvovi-
ruses, and picornaviruses, and in gorillas with expansion of
herpesviruses and reoviruses (D’Arc et al., 2018; Handley et al.,
2012). Vaccination against SIV protects animals from emergence
of these enteropathogens (Handley et al., 2016). In humans, low
CD4+ T cell counts in HIV-infected individuals are similarly as-
sociated with expansion of enteric adenoviruses and anellovi-
ruses (Monaco et al., 2016). Individuals with other sources of
immunocompromise also exhibit increased prevalence, dura-
tion, and severity of enteric viral infections (Brown et al., 2016;
Daniel-Wayman et al., 2018; Green, 2014). Enteric graft-versus-
host disease patients, after allogeneic hematopoietic stem cell
transplantation, exhibit a significant increase in the richness of
persistent eukaryotic viruses (Legoff et al., 2017). Indeed, the
presence of a dsRNA Picobirnaviridae species is predictive of
later development of graft-versus-host disease, suggesting this
could be an immune target associated with dysregulated in-
flammation (Legoff et al., 2017). Intriguingly, the human eu-
karyotic virome has also been associated with protection from
disease. Specifically, Circoviridae were enriched in healthy
controls compared with cases when the enteric virome was
analyzed longitudinally in a cohort of children at risk for auto-
immune disease type 1 diabetes (Zhao et al., 2017), suggesting
the possibility that this viral family limits immune-mediated
disease. Studies thus far emphasize the importance of adaptive
immune control of enteric viral pathogens, but continued ex-
ploration of virome changes in the context of human immune
disease will be critical to full understanding of virome effects.
Influences of the collective virome on immunity
Although PRRs can react to both intestinal bacteriophages and
eukaryotic viruses, virome-wide sensing by multiple PRRs and
the collective impact of these communities on intestinal ho-
meostasis and inflammatory responses are just beginning to be
explored. Several groups have used antiviral treatment of mice
to deplete the virome to uncover two distinct pathways bywhich
the viromemediates protective effects (Lee and Baldridge, 2019).
In one study, broad antiviral treatment was found to reduce
TLR3- or TLR7-driven production of tonic levels of type I IFN in
the intestine (Yang et al., 2016), thereby sensitizing mice to
colitis induced by chemical colitogen dextran sodium sulfate
(DSS). Supporting this observation, TLR3, TLR7, and TLR9 ago-
nists effectively improve DSS-induced colitis by stimulating
type I IFN responses (Katakura et al., 2005; Sainathan et al.,
2012; Vijay-Kumar et al., 2007). Similarly, MNoV infection
alone can help to restore intestinal morphology and lymphocyte
function in germ-free or antibiotic-treated mice by inducing
type I IFN signaling (Kernbauer et al., 2014), indicating that a
single virus may recapitulate effects of the collective virome.
MNoV can also protect antibiotic-treated mice from severe in-
fection by the bacterial pathogen Citrobacter rodentium and en-
hance colonization resistance to vancomycin-resistant Enterococcus
(Abt et al., 2016; Kernbauer et al., 2014). Type I IFN signaling
mediates these protective effects by stimulating IL-22 production
from innate lymphoid cells, in turn promoting pSTAT3 signaling in
IECs to protect from intestinal injury (Fig. 2; Neil et al., 2019).
Similar signaling pathways may also contribute to protection of
nonobese diabetic mice from development of type 1 diabetes with
MNoV infection (Pearson et al., 2019). Importantly, human pa-
tients with combined TLR3 and TLR7 genetic variants display
greater severity of ulcerative colitis (Yang et al., 2016), and in
clinical trials, topically applied TLR9 agonists can induce remission
in ulcerative colitis patients with moderate to severe activity
(Atreya et al., 2016; Atreya et al., 2018; Schmitt et al., 2020). These
results indicate sensing of the virome by TLRs and TLR-mediated
type I IFN responses help protect against or ameliorate enteric
inflammation.
The recent identification of a second pathway by which the
virome regulates the intestinal immune system suggests multi-
ple complex contributions of commensal viruses to intestinal
homeostasis. Treatment of mice with an antiviral cocktail re-
vealed that the commensal virome activates a type I and type III
IFN–independent, unconventional RIG-I–MAVS-IRF1 signaling
pathway to induce production of the cytokine IL-15 in DCs (Liu
et al., 2019). IL-15 subsequently promotes the biogenesis of in-
traepithelial lymphocytes (IELs), which are the first line of im-
mune cells in the intestinal epithelium and thus play an
important role in safeguarding the integrity of the epithelial
barrier (Fig. 2; Cheroutre et al., 2011; Liu et al., 2019). IELs are
highly relevant to antiviral defense, as activation of IELs in vivo
rapidly provokes type I and type III IFN responses to induce ISG
expression in IECs (Swamy et al., 2015). Administration of IL-15
protects antiviral-treated mice, as well as Mavs-deficient mice,
from sensitivity to DSS-induced colitis, providing another
mechanism by which the virome promotes protective effects in
the intestine (Liu et al., 2019). It is likely that other pathways by
which the complex enteric virome controls and promotes in-
testinal homeostasis remain to be discovered.
While thus far we have discussed the beneficial effects of the
enteric virome on the host, it must be emphasized that these
protective effects are context dependent. It has also been
reported that, in the setting of host genetic risk factors or
immunodeficiency, commensal viruses can contribute to path-
ological effects in the intestine (Cadwell et al., 2010;
Chamaillard et al., 2014). For instance, a common variant of
ATG16L1, a gene that mediates cellular autophagy, is associated
with increased susceptibility to Crohn’s disease and with
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morphological defects in Paneth cells (Cadwell et al., 2010).
MNoV infection of Atg16L1-mutant mice enhances intestinal pa-
thology, sensitizing Paneth cells to TNF-α–mediated necroptosis in
response to viral infection (Matsuzawa-Ishimoto et al., 2017).
Similarly, mice deficient in Il10 are also susceptible to MNoV-
triggered inflammation (Basic et al., 2014; Bolsega et al., 2019).
Further, though MNoVmay protect susceptible nonobese diabetic
mice from type 1 diabetes, rotavirus infection has the opposite
effect, instead accelerating disease, acting through TLR7 to trigger
type I IFN signaling to activate lymphocytes (Pane et al., 2016;
Pane et al., 2014). Thus, both host-specific and virome-specific
factors can ultimately contribute to observed disease phenotypes.
Conclusions and future directions
Over the last two decades, our understanding of the interplay
between the virome and the immune system has increased
dramatically, but there is still much dark matter to explore.
Improved understanding of the fundamental components of the
virome, in both health and disease and in human cohorts as well
as animal models, is crucial. Further refinement of viral data-
bases and improvements in long- and short-read sequencing
approaches, as well as improved capture of RNA genomes, will
greatly facilitate resolution of metaviromes. Ongoing efforts to
cultivate diverse phage collections will hopefully yield model
phage communities for future experimental application, and
recognition and cultivation of individual novel eukaryotic vi-
ruses will also be critically important to our understanding of
how the virome mediates effects.
Many of our experimental models to test the role of the vi-
rome can also be expanded, with more specific antiviral treat-
ments or use of germ-free mice for colonization with defined viral
species. Much intestinal virome research has relied upon single
virus infection models, and while these have proven incredibly
informative, expansion into coinfection models or use of a greater
diversity of virus types will help to separate common from unique
consequences of infections. Further, it will continue to be im-
portant to consider the intestinal—and extraintestinal—effects
that the virome has on innate and adaptive immune responses,
with an appreciation that host context is key.
Finally, while reviewed extensively elsewhere (Robinson,
2019; Walker and Baldridge, 2019), better understanding of the
interactions between the prokaryotic and eukaryotic components
of the virome and the bacteria, fungi, and other organisms com-
prising the microbiota is a critical future direction. Identifying how
the virome is regulated by and exploits the rest of the intestinal ec-
osystem will facilitate our understanding of how these communities
contribute to intestinal immune regulation and pathophysiology.
Virome–immune interactions is a new and rapidly growing field
likely to facilitate development of antiviral therapies and vaccines.
Further studies are greatly needed to fully define the contribution of
viruses to intestinal immunity, as well as to the development of in-
testinal diseases and other complex inflammatory disorders.
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Gorczyca, K. Dabrowska, B. Weber-Dabrowska, and M. Nowaczyk.
2006. Bacteriophages and transplantation tolerance. Transplant. Proc.
38:331–333. https://doi.org/10.1016/j.transproceed.2005.12.073
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